Vaccines very effective against hospital and ICU admissions, also for Delta variant COVID-19 vaccines work well in preventing people from being admitted to hospital or ICU for COVID-19, according to a new analysis by RIVM.
COVID-19 vaccination reduces transmission Vaccination against COVID-19 reduces the transmission of the virus from one person to another. This is apparent from RIVM research using data from source and contact tracing by the Municipal Public Health Services (GGDs).
Nearly 85% of people aged 18 and over have had at least one vaccination The RIVM vaccination update this week has been expanded to include three maps of the Netherlands. For the first time, it is now possible to see vaccination turnout by municipality for everyone aged 18 years and over.
INHERIT Model: a tool to jointly improve health, environmental sustainability and Health Equity RIVM is involved in the Horizon2020 project INHERIT. The first article of the INHERIT project has been published, lead-authored by RIVM.
RIVM supports WHO in national capacity building for measuring foodborne disease burden RIVM’s Collaborating Centre for Risk Assessment of Pathogens in Food and Water was invited to WHO’s side event during the 41st Codex Alimentarius Commission on July 4th 2018.
Meningococcal disease serious, but still rare Meningococcal disease is a disease caused by a bacterium, the meningococcus. There are several types of this bacterium. In most cases, it does not make you ill.
Animal-free innovations in safety assessment of chemicals How can the process of validation, acceptance and use of animal-free innovative approaches to assess the safety of chemicals be facilitated?